Oncology - Medicine.net

Cancer deaths in Italy: Environmental pollution plays an important role

by Università di BolognaGraphical abstract. Credit:Science of The Total Environment(2022). DOI: 10.1016/j.scitotenv.2022.158439Today, cancer represents the second leading cause of death in

Updated on: February 18,2024

17

Cancer deaths in Italy: Environmental pollution plays an important role

by Università di BolognaGraphical abstract. Credit:Science of The Total Environment(2022). DOI: 10.1016/j.scitotenv.2022.158439Today, cancer represents the second leading cause of death in

Updated on:February 18,2024

17

Study identifies new gene that drives colon cancer

by The Mount Sinai HospitalRecurrently dysregulated super-enhancers in CRC patients.aStudy overview. Figure adapted from SMART Servier Medical Art, reproduced with permission, license

Updated on: February 18,2024

15

Study identifies new gene that drives colon cancer

by The Mount Sinai HospitalRecurrently dysregulated super-enhancers in CRC patients.aStudy overview. Figure adapted from SMART Servier Medical Art, reproduced with permission, license

Updated on:February 18,2024

15

Even with multiple breast tumors, mastectomy isn't always necessary: Study

by Denise MannSome women with multiple breast tumors can safely be spared breast removal surgery, choosing less invasive treatment instead, new research suggests.Under certain conditions,women&n

Updated on: January 16,2024

15

Even with multiple breast tumors, mastectomy isn't always necessary: Study

by Denise MannSome women with multiple breast tumors can safely be spared breast removal surgery, choosing less invasive treatment instead, new research suggests.Under certain conditions,women&n

Updated on:January 16,2024

15

Probing RNA epigenetics and chromatin structures to predict drug resistance in leukemia

by University of Chicago Medical Center5-AZA-sensitive and 5-AZA-resistant leukemia cells have distinctly different chromatin structures. Credit: Jason ChengDrug resistance is a major obstacle to

Updated on: March 09,2024

17

Probing RNA epigenetics and chromatin structures to predict drug resistance in leukemia

by University of Chicago Medical Center5-AZA-sensitive and 5-AZA-resistant leukemia cells have distinctly different chromatin structures. Credit: Jason ChengDrug resistance is a major obstacle to

Updated on:March 09,2024

17

Discovering cancers of epigenetic origin without DNA mutation

byCNRSExample of a tumor obtained by reducing the expression levels of a Polycomb protein. On the left is an example of precursor tissue of the eye during normal development. On the right, a tum

Updated on: April 28,2024

0

Discovering cancers of epigenetic origin without DNA mutation

byCNRSExample of a tumor obtained by reducing the expression levels of a Polycomb protein. On the left is an example of precursor tissue of the eye during normal development. On the right, a tum

Updated on:April 28,2024

0

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on: April 10,2024

16

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on:April 10,2024

16

New test predicts chance of living more than a year on targeted breast cancer treatment

by Institute of Cancer ResearchBreast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR, 2011A new test could pick out wom

Updated on: May 23,2024

6

New test predicts chance of living more than a year on targeted breast cancer treatment

by Institute of Cancer ResearchBreast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR, 2011A new test could pick out wom

Updated on:May 23,2024

6

Shades of grey reveal breast tumours

by David Bradley,InderscienceMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast cancer is the second most common cancer in women. Mammography

Updated on: March 01,2024

17

Shades of grey reveal breast tumours

by David Bradley,InderscienceMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainBreast cancer is the second most common cancer in women. Mammography

Updated on:March 01,2024

17

Crucial role of JUN protein in restraining liver cancer growth discovered

by Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)Synopsis. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-024-00188-0A team of scientists led by Dr. Björn von Eyss has disc

Updated on: September 07,2024

0

Crucial role of JUN protein in restraining liver cancer growth discovered

by Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)Synopsis. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-024-00188-0A team of scientists led by Dr. Björn von Eyss has disc

Updated on:September 07,2024

0

Cancer in Europe: more cases but fewer deaths

Credit: CC0 Public DomainThe number of cancer cases has continued to rise across Europe, however mortality rates from the disease have fallen, according to the World Health Organization's "Eu

Updated on: March 06,2024

14

Cancer in Europe: more cases but fewer deaths

Credit: CC0 Public DomainThe number of cancer cases has continued to rise across Europe, however mortality rates from the disease have fallen, according to the World Health Organization's "Eu

Updated on:March 06,2024

14

'Positive' trial for Pfizer-BioNTech COVID-flu jab

Credit: Unsplash/CC0 Public DomainGermany's BioNTech and US pharmaceutical giant Pfizer on Thursday announced "positive" results from initial trials of their combined mRNA vaccine agains